# Quest Intl., Inc.

- Location (FDA's records): North Miami, FL
- FDA decisions: 25 (1989–2009): 25 510(k) clearances
- Product codes: LSE (4), LFX (2), LFZ (2), LJN (2), LYY (2), LGD (2), LKP (2), LRM (1), LFY (1), LJY (1), MID (1), JZO (1)
- Predicates its devices cite: 0 (0 its own); citations of its devices by later devices: 1 (0 its own)
- Recalls linked to its devices: 4 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms that cite its devices most
- Bio-Rad Laboratories, Inc.: 1 (https://510kreport.com/company/bio-rad-laboratories)

## Its most-cited devices
- K961053: Seraquest Rubella Igg (1996), cited by 1

## Recent decisions
- K091260: Seraquest Ebv EA-D Igg Test (Jun 8, 2009)
- K033915: Modification to Seraquest EB Vca Igg (Jan 16, 2004)
- K033780: Modification to Seraquest Vca Igm (Jan 15, 2004)
- K023593: Seraquest Anti-Thyroid Peroxidase (Tpo) (Feb 6, 2003)
- K023592: Seraquest Anti-Thyroglobulin (Jan 6, 2003)
- K003069: Anti-Cardiolipin, Multiple Autoantibodies Immunological Test System (Nov 27, 2000)
- K991975: Seraquest EB NA Igg (Nov 2, 1999)
- K990410: Seraquest EB Vca Igg (Oct 28, 1999)

Source page: https://510kreport.com/company/quest-intl